Journal of Endocrinological Investigation

, Volume 14, Issue 7, pp 569–575 | Cite as

The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome

  • J. Slowińska-Srzednicka
  • S. Zgliczyński
  • M. Wierzbicki
  • M. Srzednicki
  • U. Stopińska-Gluszak
  • W. Zgliczyński
  • P. Soszyński
  • E. Chotkowska
  • M. Bednarska
  • Z. Sadowski


In order to establish the role of insulin in the pathogenesis of lipid abnormalities in hyperandrogenic women with the polycystic ovary syndrome (PCO) 49 women aged 18 to 35 yr with a normal glucose tolerance test were studied. They were divided into two groups: 27 women with PCO (9 obese and 18 nonobese), and 22 healthy women (12 with simple obesity and 10 with normal body weight). In the PCO group, the fasting insulin levels and the insulin response to oral glucose load were higher than in the matched controls. Significantly lower levels of HDL2-cholesterol and higher levels of apolipoprotein B were observed in obese and non nonobese PCO patients. In obese women with PCO this was associated with lower levels of HDL-cholesterol and apolipoprotein A-l (Apo A-l), whereas the levels of total triglycerides and VLDL-triglycerides (VLDL-TG) were increased. Multiple regression analysis in PCO women, after adjustment for age, body mass index and the levels of insulin and sex hormones, showed a strong positive correlation between the fasting insulin levels and total triglycerides and VLDL-TG, while a negative correlation was found between fasting insulin levels and apo A-l. These results indicate that hyperinsulinemia may play a role in the development of lipid disturbances in women with the PCO.


Polycystic Ovary Syndrome insulin lipoproteins sex hormones 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Johansson S., Bondjers G., Fager G., Wedel H., Tsipogiani A., Olofsson S., Vedin A., Wikiund O., Wilhelmsson C. Serum lipids and apolipoprotein levels in women with acute myocardial infarction. Arteriosclerosis 8: 742, 1988.PubMedCrossRefGoogle Scholar
  2. 2.
    Lapidus L., Bangtsson C., Lindquist O., Sigurdsson J.A., Rybo E. Triglycerides — main lipid risk factor for cardiovascular disease in women? Acta Med. Scand. 217: 481, 1985.PubMedCrossRefGoogle Scholar
  3. 3.
    Godsland J.F., Wynn V., Path F.R.C., Crook D., Miller N.E. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. Am. Heart J. 114: 1467, 1987.PubMedCrossRefGoogle Scholar
  4. 4.
    Franks S. Polycystic ovary syndrome: a changing perspective. Clin. Endocrinol. (Oxf.) 31: 87, 1989.CrossRefGoogle Scholar
  5. 5.
    Smith S., Ravinkar V.A., Barbieri R.L. Androgen and insulin response to an oral glucose challenge in hyperandrogenic women. Fertil. Steril. 48: 72, 1987.PubMedGoogle Scholar
  6. 6.
    Burghen G.A., Givens J.A., Kitabchi A.E. Correlation of hyperandrogenism with hyperinsulinemia in polycystic ovarian disease. J. Clin. Endocrinol. Metab. 50: 113, 1980.PubMedCrossRefGoogle Scholar
  7. 7.
    Lithell H., Nillius S.J., Bergh T., Selinus J. Metabolic profile in obese women with polycystic ovary syndrome. Int. J. Obes. 11: 1, 1987.PubMedGoogle Scholar
  8. 8.
    Wild R.A., Painter P.C., Coulson P.B., Carruth K.B., Ranney G.B. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 61: 946, 1985.PubMedCrossRefGoogle Scholar
  9. 9.
    Rebuffe-Scrive M., Cullberg G., Lundberg P.A., Lindsted G., Björntorp P. Anthropometric variables and metabolism in polycystic ovarian disease. Horm. Metab. Res 21: 391, 1989.PubMedCrossRefGoogle Scholar
  10. 10.
    Mattson L.A., Cullberg G., Hamberger L, Samsioe G., Silferstoipe G. Lipid metabolism in women with polycystic ovary syndrome: Possible implication for an increased risk of coronary heart disease. Fertil. Steril. 42: 579, 1984.Google Scholar
  11. 11.
    Chang R.J., Nakamura R.M., Judd H.L, Kaplan S.A. Insulin resistance in nonobese patients with polycystic ovary disease. J. Clin. Endocrinol. Metab. 57: 356, 1983.PubMedCrossRefGoogle Scholar
  12. 12.
    Barbieri R.L, Smith S., Ryan K.H. The role of hyperinsulienemia in the pathogenesis of ovarian hyperandrogenism. Fertil. Steril. 50: 197, 1988.PubMedGoogle Scholar
  13. 13.
    Pyöräliä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2: 131, 1979.CrossRefGoogle Scholar
  14. 14.
    Ducimetiere P., Eschwege E., Papoz L., Richard J.L., Claude J.R., Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19: 205, 1980.PubMedCrossRefGoogle Scholar
  15. 15.
    Welborn T.A., Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentration. Diabetes Care 2: 156, 1979.CrossRefGoogle Scholar
  16. 16.
    Reaven G.M., Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 37: 1595, 1988.PubMedCrossRefGoogle Scholar
  17. 17.
    Tobey T.A., Greenfield M., Kraemer F., Reaven G.M. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man. Metabolism 30: 165, 1981.PubMedCrossRefGoogle Scholar
  18. 18.
    Gidez L.J., Miller G.J., Burstein M., Eder H.A. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J. Lipid Res. 23: 1206, 1982.PubMedGoogle Scholar
  19. 19.
    Grafnetter D., Fodor J., Teply V., Zacek K. The effect of storage on levels of cholesterol in serum as measured by a simple, direct method. Clin. Chim. Acta 16: 33, 1967.PubMedCrossRefGoogle Scholar
  20. 20.
    Wahlefeld A.W. Triglyceride determination after enzymatic hydrolysis. In: Bergnayer H.U. (Ed.), Methods in enzymatic analysis. Vol D. Academic Press, New York, 1974, p. 72.Google Scholar
  21. 21.
    Slowinska-Srzednicka J., Zgliczynski S., Ciswicka-Sznajderman M., Srzednicki M., Soszynski P., Bednarska M., Woroszylska M., Ruzyllo W., Sadowski Z. Decreased plasma dehydroepiandrosterone sulphate and dihydrotestosterone concentrations in young men after myocardial infarction. Atherosclerosis 79: 197, 1989.PubMedCrossRefGoogle Scholar
  22. 22.
    Foster D.W. Insulin resistance — a secret killer? N. Engl. J. Med. 320: 733, 1989.PubMedCrossRefGoogle Scholar
  23. 23.
    Slowinska-Srzednicka J., Zgliczynski S., Soszynski P., Zgliczynski W., Jeske W. High blood pressure and hyperinsulinemia in acromegaly and obesity. Clin. Exp. Hypertens. All: 407, 1989.CrossRefGoogle Scholar
  24. 24.
    Reaven G.M., Hoffman B.B. A role for insulin in the aetiology and course of hypertension. Lancet 2: 435, 1987.PubMedCrossRefGoogle Scholar
  25. 25.
    Nestler J.E., Clore J.N., Blackard W.G. The central role of obesity (hyperinsulinemia) in the pathogenesis of polycystic ovary syndrome. Am. J. Obstet. Gynecol. 161: 1095, 1989.PubMedCrossRefGoogle Scholar
  26. 26.
    Poison D.W., Adams J., Wadsworth J., Franks S. Polycystic ovaries — a common finding in normal women. Lancet 1: 870, 1988.Google Scholar
  27. 27.
    Castelli W.P. The triglyceride issue: A view from Framingham. Am. Heart J. 112: 432, 1986.PubMedCrossRefGoogle Scholar
  28. 28.
    Haffner S.M., Katz M.S., Stern M.P., Dunn J.F. The relationship of sex hormones to hyperinsulinemia and hyperglycemia. Metabolism 37: 683, 1988.PubMedCrossRefGoogle Scholar
  29. 29.
    Nestler J.E., Barlascini C.O., Matt D.W., Steingold K.A., Plymate S.R., Clore J.N., Blackard W.G. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 68: 1027, 1989.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1991

Authors and Affiliations

  • J. Slowińska-Srzednicka
    • 1
    • 3
  • S. Zgliczyński
    • 1
  • M. Wierzbicki
    • 1
  • M. Srzednicki
    • 2
  • U. Stopińska-Gluszak
    • 1
  • W. Zgliczyński
    • 1
  • P. Soszyński
    • 1
  • E. Chotkowska
    • 2
  • M. Bednarska
    • 2
  • Z. Sadowski
    • 2
  1. 1.Department of EndocrinologyMedical Center for Postgraduate EducationWarsawPoland
  2. 2.Institute of CardiologyWarsawPoland
  3. 3.Department of EndocrinologyBielanski HospitalWarsawPoland

Personalised recommendations